Evaluation of the effectiveness of remdesivir in severe COVID-19 using observational data from a prospective national cohort study

B N Arch, D Kovacs, J T Scott, A P Jones, E M Harrison, A Rosala-Hallas, C G Gamble, P J M Openshaw, J K Baillie, M G Semple ISARIC4C Investigators
doi: https://doi.org/10.1101/2021.06.18.21259072

Article usage

Article usage: June 2021 to December 2024

AbstractFullPdf
Jun 202116603317
Jul 202146234128
Aug 20214842282
Sep 202138520116
Oct 20212301370
Nov 2021248870
Dec 2021189334
Jan 20221571483
Feb 2022117338
Mar 202232915113
Apr 2022217438
May 2022156638
Jun 20221351030
Jul 2022112124
Aug 202292622
Sep 202293317
Oct 202279224
Nov 202271817
Dec 202264120
Jan 2023431011
Feb 2023611424
Mar 202357213
Apr 2023631238
May 202348421
Jun 202325411
Jul 202341415
Aug 2023351718
Sep 202344513
Oct 202338813
Nov 2023471315
Dec 202333215
Jan 202460014
Feb 202435612
Mar 2024321117
Apr 2024311016
May 202448616
Jun 202424421
Jul 202434217
Aug 202445620
Sep 2024511015
Oct 2024241018
Nov 202429818
Dec 20248011
Back to top
Posted March 09, 2022.
Download PDF

Supplementary Material

Data/Code
Email
Evaluation of the effectiveness of remdesivir in severe COVID-19 using observational data from a prospective national cohort study
B N Arch, D Kovacs, J T Scott, A P Jones, E M Harrison, A Rosala-Hallas, C G Gamble, P J M Openshaw, J K Baillie, M G Semple
medRxiv 2021.06.18.21259072; doi: https://doi.org/10.1101/2021.06.18.21259072
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area